Bionano Genomics, Inc. (BNGO)

USD 4.05

(1.25%)

Revenue Summary of Bionano Genomics, Inc.

  • Bionano Genomics, Inc.'s latest annual revenue in 2023 was 36.11 Million USD , up 29.9% from previous year.
  • Bionano Genomics, Inc.'s latest quarterly revenue in 2024 Q2 was 7.77 Million USD , down -11.38% from previous quarter.
  • Bionano Genomics, Inc. reported a annual revenue of 27.8 Million USD in annual revenue 2022, up 54.62% from previous year.
  • Bionano Genomics, Inc. reported a annual revenue of 17.98 Million USD in annual revenue 2021, up 111.47% from previous year.
  • Bionano Genomics, Inc. reported a quarterly revenue of 8.76 Million USD for 2024 Q1, down -18.21% from previous quarter.
  • Bionano Genomics, Inc. reported a quarterly revenue of 9.31 Million USD for 2023 Q3, up 7.57% from previous quarter.

Annual Revenue Chart of Bionano Genomics, Inc. (2023 - 2016)

Historical Annual Revenue of Bionano Genomics, Inc. (2023 - 2016)

Year Revenue Revenue Growth
2023 36.11 Million USD 29.9%
2022 27.8 Million USD 54.62%
2021 17.98 Million USD 111.47%
2020 8.5 Million USD -16.06%
2019 10.12 Million USD -15.59%
2018 12 Million USD 26.26%
2017 9.5 Million USD 39.93%
2016 6.79 Million USD 0.0%

Peer Revenue Comparison of Bionano Genomics, Inc.

Name Revenue Revenue Difference
Aclaris Therapeutics, Inc. 31.24 Million USD -15.575%
Biodesix, Inc. 49.08 Million USD 26.425%
bioAffinity Technologies, Inc. 2.53 Million USD -1326.101%
Castle Biosciences, Inc. 219.78 Million USD 83.568%
DarioHealth Corp. 20.35 Million USD -77.457%
Exact Sciences Corporation 2.49 Billion USD 98.555%
IDEXX Laboratories, Inc. 3.66 Billion USD 99.013%
Illumina, Inc. 4.5 Billion USD 99.198%
Intelligent Bio Solutions Inc. 3.11 Million USD -1060.622%
iSpecimen Inc. 9.92 Million USD -263.772%
Standard BioTools Inc. 106.34 Million USD 66.037%
23andMe Holding Co. 219.63 Million USD 83.557%
Medpace Holdings, Inc. 1.88 Billion USD 98.085%
NeoGenomics, Inc. 591.64 Million USD 93.896%
Inotiv, Inc. 572.42 Million USD 93.691%
Psychemedics Corporation 22.09 Million USD -63.436%
Prenetics Global Limited 21.74 Million USD -66.107%
Precipio, Inc. 15.19 Million USD -137.652%
RadNet, Inc. 1.61 Billion USD 97.766%
Sotera Health Company 1.04 Billion USD 96.558%
Star Equity Holdings, Inc. 45.78 Million USD 21.118%
Exagen Inc. 52.54 Million USD 31.27%
Natera, Inc. 1.08 Billion USD 96.664%
Aspira Women's Health Inc. 9.15 Million USD -294.538%
Neogen Corporation 924.22 Million USD 96.092%
Myriad Genetics, Inc. 678.4 Million USD 94.676%
ICON Public Limited Company 8.12 Billion USD 99.555%
CareDx, Inc 280.32 Million USD 87.116%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 312.97 Million USD 88.46%
Guardant Health, Inc. 563.94 Million USD 93.596%
BioNexus Gene Lab Corp. 9.77 Million USD -269.632%
Fulgent Genetics, Inc. 289.21 Million USD 87.512%
Sera Prognostics, Inc. 306 Thousand USD -11702.614%
OPKO Health, Inc. 863.49 Million USD 95.817%
Personalis, Inc. 73.48 Million USD 50.85%
Applied DNA Sciences, Inc. 13.36 Million USD -170.179%
Star Equity Holdings, Inc. 45.78 Million USD 21.118%
MDxHealth SA 70.19 Million USD 48.548%
Prenetics Global Limited 21.74 Million USD -66.107%
ENDRA Life Sciences Inc. - USD -Infinity%
Mainz Biomed B.V. 895.47 Thousand USD -3933.149%
Trinity Biotech plc 56.83 Million USD 36.451%
Neuronetics, Inc. 71.34 Million USD 49.381%
bioAffinity Technologies, Inc. 2.53 Million USD -1326.101%